Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities

被引:34
|
作者
Adir, Yochai [1 ]
Guazzi, Marco [2 ]
Offer, Amir [3 ,4 ]
Temporelli, Pier Luigi [5 ]
Cannito, Antonia [6 ]
Ghio, Stefano [6 ]
机构
[1] Technion, Inst Technol, Fac Med, Pulm Di,Lady Davis Carmel Med Ctr, Haifa, Israel
[2] Univ Milan, IRCCS, Univ Cardiol Dept, Policlin San Donato, Piazza Malan 2, I-20097 Milan, Italy
[3] Bar Ilan Univ, Padeh Poriya Med Ctr Tiberias, Dept Cardiol, Safed, Israel
[4] Bar Ilan Univ, Fac Med, Safed, Israel
[5] IRCCS, Ist Clin Sci Maugeri, Div Cardiol, Veruno, NO, Italy
[6] Fdn IRCCS, Div Cardiol, Policlin San Matteo, Pavia, Italy
关键词
PRESSURE-GRADIENT; ARTERIAL COMPLIANCE; ASSOCIATION; DYSFUNCTION; PREDICTOR; DIAGNOSIS;
D O I
10.1016/j.ahj.2017.06.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The current understanding of pulmonary hypertension (PH) due to left ventricular diseases does not distinguish heart failure (HF) with reduced ejection fraction (HFrEF) from HF and preserved ejection fraction (HFpEF), in terms of pulmonary hemodynamics. The value of pulmonary vascular compliance (PCa) and diastolic pulmonary gradient (DPG) as predictors of survival in either HF syndrome is controversial. The aims of our study were to compare the pulmonary hemodynamics in the two HF phenotypes, given similar values of pulmonary artery wedge pressure (PAWP), and to evaluate the impact of PCa and DPG on survival. Methods We retrospectively reviewed the charts of 168 PH-HFrEF and 86 PH-HFpEF patients. The independent association of PCa and DPG with prognosis was assessed by means of a Cox proportional hazard model. All cause survival was analyzed over an average follow-up period of 50 months. Results PH-HFpEF patients had a significantly higher DPG than PH-HFrEF patients (6.1 +/- 7.1 vs 1.8 +/- 4.5 mmHg, adjusted P =.025). PCa was similar in PH-HFpEF and PH-HFrEF. PCa was a significant predictor of survival, according to previously described preset cutoffs (2.15 mL/mmHg in HFrEF and 1.1 mL/mmHg in HFpEF) and based on a continuous scale; whereas DPG had no impact on survival in both patients groups. Conclusion Our findings suggest that for similar levels of PAWP, pulmonary circulation may be stiffer in patients with HFpEF-PH than patients with HFrEF-PH, leading to higher DPGs. Nonetheless, PCa rather than DPG emerged as the stronger predictor of survival in both left-sided PH phenotypes.
引用
收藏
页码:120 / 127
页数:8
相关论文
共 50 条
  • [41] Pulmonary Arterial Reactivity in Heart Failure with Preserved Ejection Fraction Induced Pulmonary Hypertension Similar to Pulmonary Arterial Hypertension
    Salamon, Jason N.
    Mannem, Santhosh
    Mazurek, Jeremy
    Zolty, Ronald
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (08) : S3 - S4
  • [42] Novel insights into the pathobiology of pulmonary hypertension in heart failure with preserved ejection fraction
    Aradhyula, Vaishnavi
    Vyas, Rohit
    Dube, Prabhatchandra
    Haller, Steven T.
    Gupta, Rajesh
    Maddipati, Krishna Rao
    Kennedy, David J.
    Khouri, Samer J.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2024, 326 (06): : H1498 - H1514
  • [43] Tofogliflozin Improves Pulmonary Hypertension With Heart Failure With Preserved Ejection Fraction Mice
    Joki, Yusuke
    Konishi, Hakuoh
    Takasu, Kiyoshi
    Minamino, Tohru
    CIRCULATION, 2020, 142
  • [44] Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial
    Dachs, Theresa-Marie
    Duca, Franz
    Rettl, Rene
    Binder-Rodriguez, Christina
    Dalos, Daniel
    Ligios, Luciana Camuz
    Kammerlander, Andreas
    Grunig, Ekkehard
    Pretsch, Ingrid
    Steringer-Mascherbauer, Regina
    Ablasser, Klemens
    Wargenau, Manfred
    Mascherbauer, Julia
    Lang, Irene M.
    Hengstenberg, Christian
    Badr-Eslam, Roza
    Kastner, Johannes
    Bonderman, Diana
    EUROPEAN HEART JOURNAL, 2022, 43 (36) : 3402 - 3413
  • [45] Impact of the New Definition of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
    Sera, Fusako
    Ohtani, Tomohito
    Nakamoto, Kei
    Hikoso, Shungo
    Nakatani, Daisaku
    Tamaki, Shunsuke
    Yano, Masamichi
    Hayashi, Takaharu
    Nakagawa, Akito
    Nakagawa, Yusuke
    Yasumura, Yoshio
    Yamada, Takahisa
    Yamauchi-Takihara, Keiko
    Sakata, Yasushi
    CIRCULATION, 2020, 142
  • [46] REDUCED GAS TRANSFER (TLCO) PREDICTS POOR OUTCOME IN PATIENTS WITH PULMONARY HYPERTENSION AND HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Hussain, N.
    Ramjug, S.
    Billings, C.
    Hurdman, J.
    Elliot, C. A.
    Condliffe, R.
    Kiely, D. G.
    THORAX, 2014, 69 : A148 - A148
  • [47] Reduced Gas Transfer (tlco) Predicts Poor Outcome In Patients With Pulmonary Hypertension And Heart Failure With Preserved Ejection Fraction
    Hussain, N.
    Ramjug, S.
    Billings, C. G.
    Hurdman, J.
    Elliot, C.
    Condliffe, R.
    Kiely, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [48] Risk assessment in pulmonary hypertension associated with heart failure and preserved ejection fraction
    Agarwal, Richa
    Shah, Sanjiv J.
    Foreman, Aimee J.
    Glassner, Cherylanne
    Bartolome, Sonja D.
    Safdar, Zeenat
    Coslet, Sandra L.
    Anderson, Allen S.
    Gomberg-Maitland, Mardi
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (05): : 467 - 477
  • [49] Pulmonary arterial hypertension and heart failure with preserved ejection fraction: are they so discordant?
    Ruocco, Gaetano
    Gavazzi, Antonello
    Gonnelli, Stefano
    Palazzuoli, Alberto
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2020, 10 (03) : 534 - 545
  • [50] Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors
    Ovchinnikov, Artem
    Potekhina, Alexandra
    Belyavskiy, Evgeny
    Ageev, Fail
    PHARMACEUTICALS, 2022, 15 (08)